AGP Executive Report
Last update: 10 hours agoFinland Alcohol Watch: THL reports recorded alcohol consumption in Finland fell 4.5% in 2025 to about 6.9 litres of pure alcohol per resident aged 15+, with declines across retail and restaurants (strong beer was the only category that grew). Long COVID Brain Clue: Finnish researchers found no widespread brain inflammation in people with long COVID; instead, scans pointed to heightened activity in emotion, stress and memory-related regions. Cancer & Heart Risk Research: A JAMA Network Open study links post-diagnostic statin use with lower mortality in early breast cancer hormone-receptor subtypes, while other studies explore new cardiovascular risk markers in HIV and immune-inflammation signals in liver cancer. Mental Health Care Policy: A Karolinska Institutet doctoral thesis says coercive measures in inpatient child and adolescent psychiatry remain common and vary widely, and that stricter Swedish rules didn’t reduce coercion. Alzheimer’s & Lithium: A Finnish-led cell study suggests lithium affects far more processes inside Alzheimer’s cells than previously mapped, potentially explaining why earlier human trial benefits were inconsistent. Biotech Pipeline: Herantis says the FDA found its HER-096 Phase 2a plan appropriate for early Parkinson’s, and 3PBIOVIAN expands mammalian biomanufacturing with an added 2,000 L bioreactor. Nutrition & Sustainability: Raisio secured funding to turn grain processing side streams into functional fiber ingredients, and an EU-backed VTT-led project (Proscale) aims to scale microbial proteins using food waste.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.